Lifecore Biomedical Inc (LFCR)
6.98
-0.50
(-6.68%)
USD |
NASDAQ |
Nov 21, 16:00
6.975
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical EPS Diluted (Quarterly): -0.53 for Aug. 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -0.53 |
| May 31, 2024 | -0.23 |
| February 29, 2024 | 0.42 |
| November 30, 2023 | 0.39 |
| August 31, 2023 | -0.35 |
| May 31, 2023 | -1.19 |
| February 28, 2023 | -1.20 |
| November 30, 2022 | -0.43 |
| August 31, 2022 | -0.37 |
| May 31, 2022 | -1.24 |
| February 28, 2022 | -0.45 |
| November 30, 2021 | -1.30 |
| August 31, 2021 | -0.32 |
| May 31, 2021 | -0.10 |
| February 28, 2021 | -0.19 |
| November 30, 2020 | -0.45 |
| August 31, 2020 | -0.38 |
| May 31, 2020 | -0.52 |
| February 29, 2020 | -0.39 |
| November 30, 2019 | -0.23 |
| August 31, 2019 | -0.16 |
| May 31, 2019 | -0.01 |
| February 28, 2019 | 0.03 |
| November 30, 2018 | -0.02 |
| August 31, 2018 | 0.01 |
| Date | Value |
|---|---|
| May 31, 2018 | 0.22 |
| February 28, 2018 | 0.57 |
| November 30, 2017 | 0.02 |
| August 31, 2017 | 0.08 |
| May 31, 2017 | 0.0892 |
| February 28, 2017 | 0.13 |
| November 30, 2016 | 0.05 |
| August 31, 2016 | 0.12 |
| May 31, 2016 | 0.17 |
| February 29, 2016 | -0.78 |
| November 30, 2015 | 0.07 |
| August 31, 2015 | 0.11 |
| May 31, 2015 | 0.15 |
| February 28, 2015 | 0.14 |
| November 30, 2014 | 0.12 |
| August 31, 2014 | 0.09 |
| May 31, 2014 | 0.1694 |
| February 28, 2014 | 0.24 |
| November 30, 2013 | 0.13 |
| August 31, 2013 | 0.18 |
| May 31, 2013 | 0.17 |
| February 28, 2013 | 0.18 |
| November 30, 2012 | 0.34 |
| August 31, 2012 | 0.17 |
| May 31, 2012 | 0.1084 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.30
Minimum
Nov 2021
0.42
Maximum
Feb 2024
-0.453
Average
-0.385
Median
EPS Diluted (Quarterly) Benchmarks
| AngioDynamics Inc | -0.31 |
| Precision Optics Corp Inc | -0.21 |
| Sage Therapeutics Inc | -1.53 |
| Outset Medical Inc | -0.55 |
| NovaBay Pharmaceuticals Inc | -0.60 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.23M |
| Revenue (Quarterly) | 24.70M |
| Total Expenses (Quarterly) | 35.81M |
| Enterprise Value | 379.46M |
| Gross Profit Margin (Quarterly) | 21.81% |
| Profit Margin (Quarterly) | -65.70% |
| Earnings Yield | 0.72% |
| Normalized Earnings Yield | -12.75 |